Sampre Nutritions Complete Financial Statements
In FY2026, Sampre Nutritions (SAMPRE) reported revenue ₹16 Cr, net profit ₹1 Cr and EPS ₹0.64, with a net profit margin of 6.3% and ROE of 1.1%. Full financial statements from FY2023 to FY2026 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Sampre Nutritions stock price NSE.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SAMPRE Revenue, Net Profit & EBITDA — Year-on-Year Growth
SAMPRE YoY (Mar 2025 vs Mar 2026) — revenue +100.0%, net profit +114.3%, EBITDA +116.7%, expenses +7.1%. Examine SAMPRE quarterly results for recent quarterly revenue, profit and EPS trends.
SAMPRE Income Statement — Revenue, EBITDA & Net Profit
Sampre Nutritions revenue ₹16 Cr, EBITDA ₹1 Cr, net profit ₹1 Cr, EPS ₹0.64 (2026) — net profit margin 6.3%. Analyse SAMPRE promoter holding to track promoter, FII and institutional holdings.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16 | 10 | 8 | 11 | 7 | 7 | 5 | 5 | 6 |
| Expenses | 15 | 8 | 14 | 10 | 6 | 6 | 3 | 4 | 5 |
| EBITDA | 1 | 2 | -6 | 1 | 2 | 1 | 2 | 1 | 1 |
| Operating Profit Margin % | 3.00% | 20.00% | -81.00% | 13.00% | 20.00% | 14.00% | 43.00% | 21.00% | 8.00% |
| Depreciation | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
| Interest | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 |
| Profit Before Tax | 0 | 1 | -7 | 1 | 1 | 0 | 1 | 0 | -1 |
| Tax | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | -7 | 1 | 1 | 0 | 1 | 0 | -1 |
| Earnings Per Share (₹) | 0.64 | 0.41 | -3.50 | 0.34 | 0.06 | 0.18 | 0.65 | 0.11 | -0.30 |
SAMPRE Balance Sheet — Assets, Liabilities & Shareholders' Equity
SAMPRE total assets ₹115 Cr, total equity ₹91 Cr, total liabilities ₹ Cr (2025) — ROE 1.1%.
| Particulars | 2025 | 2024 | 2023 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 115 | 45 | 44 |
| Current Assets | 16 | 16 | 16 |
| Fixed Assets | 20 | 21 | 21 |
| Capital Work in Progress | 5 | 6 | 4 |
| Investments | 74 | 0 | 0 |
| Other Assets | 17 | 18 | 19 |
| LIABILITIES | |||
| Total Liabilities | |||
| Current Liabilities | 11 | 10 | 11 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | 91 | 23 | 21 |
| Share Capital | 21 | 7 | 7 |
| Reserves & Surplus | 68 | 12 | 12 |
SAMPRE Cash Flow Statement — Operating, Investing & Financing
Sampre Nutritions operating cash flow ₹0 Cr, investing ₹-75 Cr, financing ₹75 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 |
|---|---|---|---|
| Operating Activities | 0 | 4 | 1 |
| Investing Activities | -75 | -4 | -4 |
| Financing Activities | 75 | 0 | 4 |
| Net Cash Flow | 0 | 0 | 0 |